Skip Navigation

Pharmacology

Citations 1-10 of 32 total displayed.

Most recent content (1 Jul 2008):

CLINICAL
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
K. L. Hyrich, M. Lunt, W. G. Dixon, K. D. Watson, D. P. M. Symmons, and on behalf of the BSR Biologics Register
Rheumatology 2008; 47: 1000-1005. [Abstract] [Full Text]  

CLINICAL
Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept
J. C. Cole, T. Li, P. Lin, R. MacLean, and G. V. Wallenstein
Rheumatology 2008; 47: 1044-1050. [Abstract] [Full Text]  

CLINICAL
Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population
C. G. Grijalva, C. P. Chung, C. M. Stein, E. F. Mitchel, Jr, and M. R. Griffin
Rheumatology 2008; 47: 1061-1064. [Abstract] [Full Text] [ Supplementary Data ]  

CLINICAL
Assessment of anti-TNF-{alpha} efficacy in rheumatoid arthritis: is 3 months sufficient?
J. M. Pocock, J. C. Vasconcelos, and A. J. K. Östör
Rheumatology 2008; 47: 1073-1076. [Abstract] [Full Text] [ Supplementary Data ]  

CLINICAL
Cost–effectiveness of advising the use of topical or oral ibuprofen for knee pain; the TOIB study [ISRCTN: 79353052]
E. Castelnuovo, P. Cross, S. Mt-Isa, A. Spencer, and M. Underwood on behalf of the TOIB study team
Rheumatology 2008; 47: 1077-1081. [Abstract] [Full Text] [ Supplementary Data ]  

CASE REPORTS
Reversible Hodgkin's lymphoma associated with Epstein–Barr virus occurring during azathioprine therapy for SLE
S. J. Evans, D. K. Watson, and M. O'Sullivan
Rheumatology 2008; 47: 1103-1104. [Extract] [Full Text]  

CASE REPORTS
Rituximab is effective in the treatment of refractory Churg–Strauss syndrome and is associated with diminished T-cell interleukin-5 production
R. J. Pepper, M. A. Fabre, C. Pavesio, G. Gaskin, R. B. Jones, D. Jayne, C. D. Pusey, and A. D. Salama
Rheumatology 2008; 47: 1104-1105. [Extract] [Full Text]  

Past content (since Sep 2007):

ARTICLES
Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs
M. Østensen, M. Lockshin, A. Doria, G. Valesini, P. Meroni, C. Gordon, A. Brucato, and A. Tincani
Rheumatology 2008; 47: iii28-iii31. [Abstract] [Full Text]  

REPORT
A new paradigm for musculoskeletal clinical trials in the UK: the Arthritis Research Campaign (ARC) Clinical Studies Groups initiative
A. Silman
Rheumatology 2008; 47: 777-779. [Abstract] [Full Text]  

CASE REPORTS
Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis
M. Hellmann, N. Jung, K. Owczarczyk, M. Hallek, and A. Rubbert
Rheumatology 2008; 47: 929-930. [Extract] [Full Text]  

[Next page]
Pages: 1 2 3 4

* Collected Resources Home

* Related collections:
 Rheumatology
 Benign Joint Hypermobility Syndrome
 Crystal Arthritis
 Diagnostics and Imaging Procedures
 Education
 Experimental Arthritis
 Fibromyalgia
 Health Economics
 Historical Medicine
 Immunogenetics
 Myositis and Muscle Disease
 Osteoarthritis and Cartilage
 Osteoporosis and Metabolic Bone Disease
 Pharmacology
 Pregnancy and Rheumatic Diseases
 Psychology: Measurement and Management of Pain
 Rehabilitation
 Rheumatoid Arthritis
 Sjogren's Syndrome
 Soft Tissue Rheumatism
 Spinal Pain
 Spondylarthropathies
 Systemic Lupus Erythematosus and Autoimmunity
 Systemic Sclerosis
 Vasculitis